UPDATE: BMO Capital Downgrades Nuvation Bio Inc (NUVB) to Market Perform Aug 1, 2022 04:23PM
Nuvation Bio Inc (NUVB) PT Lowered to $12 at BMO Capital on Lower Assumed Penetration Rates, but Optimistic Reiterated Ahead of Phase 1 NUV-422 Readout Mar 22, 2022 06:39AM
Nuvation Bio Inc (NUVB) PT Lowered to $12 at BMO Capital on Reduced Breast Cancer Assumptions Mar 22, 2022 06:37AM
UPDATE: BMO Capital Starts Nuvation Bio Inc (NUVB) at Outperform Mar 8, 2021 04:31AM